LBT Innovations (ASX:LBT) Debt-to-Equity : 0.61 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Debt-to-Equity?

LBT Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.21 Mil. LBT Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.34 Mil. LBT Innovations's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$2.55 Mil. LBT Innovations's debt to equity for the quarter that ended in Dec. 2023 was 0.61.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for LBT Innovations's Debt-to-Equity or its related term are showing as below:

ASX:LBT' s Debt-to-Equity Range Over the Past 10 Years
Min: -32.26 Med: 0.09 Max: 0.61
Current: 0.61

During the past 13 years, the highest Debt-to-Equity Ratio of LBT Innovations was 0.61. The lowest was -32.26. And the median was 0.09.

ASX:LBT's Debt-to-Equity is ranked worse than
77.35% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs ASX:LBT: 0.61

LBT Innovations Debt-to-Equity Historical Data

The historical data trend for LBT Innovations's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations Debt-to-Equity Chart

LBT Innovations Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.09

0.16

0.20

-32.26

LBT Innovations Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.08	0.20	0.09	-32.26	0.61

Competitive Comparison of LBT Innovations's Debt-to-Equity

For the Medical Devices subindustry, LBT Innovations's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LBT Innovations's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LBT Innovations's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where LBT Innovations's Debt-to-Equity falls into.

LBT Innovations Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

LBT Innovations's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.194	+	2.193)	/	-0.105
	=	-32.26

LBT Innovations's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.212	+	1.337)	/	2.552
	=	0.61

LBT Innovations (ASX:LBT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

LBT Innovations Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Anster Street, Adelaide, SA, AUS, 5000

Website

https://www.lbtinnovations.com

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines